Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 2, 2017
[ Thu, Nov 02nd 2017
] - WOPRAI
[ Thu, Nov 02nd 2017
] - WOPRAI
[ Thu, Nov 02nd 2017
] - WOPRAI
[ Thu, Nov 02nd 2017
] - WOPRAI
[ Thu, Nov 02nd 2017
] - WOPRAI
Wed, November 1, 2017
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
Christopher Turnure Maintained (SRE) at Hold and Held Target at $62 on, Nov 1st, 2017
Christopher Turnure of JP Morgan, Maintained "Sempra" (SRE) at Hold and Held Target at $62 on, Nov 1st, 2017.
Christopher has made no other calls on SRE in the last 4 months.
There are 3 other peers that have a rating on SRE. Out of the 3 peers that are also analyzing SRE, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Christopher
- Michael Lapides of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Wednesday, October 11th, 2017
- Sarah Akers of "Wells Fargo" Maintained at Buy with Decreased Target to $64 on, Tuesday, October 10th, 2017
- Stephen Byrd of "Morgan Stanley" Maintained at Buy with Increased Target to $67 on, Thursday, August 10th, 2017
